BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22518006)

  • 1. Podocyte-specific loss of Cdc42 leads to congenital nephropathy.
    Scott RP; Hawley SP; Ruston J; Du J; Brakebusch C; Jones N; Pawson T
    J Am Soc Nephrol; 2012 Jul; 23(7):1149-54. PubMed ID: 22518006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury.
    Blattner SM; Hodgin JB; Nishio M; Wylie SA; Saha J; Soofi AA; Vining C; Randolph A; Herbach N; Wanke R; Atkins KB; Gyung Kang H; Henger A; Brakebusch C; Holzman LB; Kretzler M
    Kidney Int; 2013 Nov; 84(5):920-30. PubMed ID: 23677246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosage-dependent role of Rac1 in podocyte injury.
    Wan X; Lee MS; Zhou W
    Am J Physiol Renal Physiol; 2016 Apr; 310(8):F777-F784. PubMed ID: 26792065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of Rho GTPase Activity in Podocytes.
    Matsuda J; Takano T
    Methods Mol Biol; 2023; 2664():343-349. PubMed ID: 37423999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podocyte Geranylgeranyl Transferase Type-I Is Essential for Maintenance of the Glomerular Filtration Barrier.
    Boi R; Bergwall L; Ebefors K; Bergö MO; Nyström J; Buvall L
    J Am Soc Nephrol; 2023 Apr; 34(4):641-655. PubMed ID: 36735952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Rho-GTPases and their regulatory proteins in glomerular podocyte function.
    Mouawad F; Tsui H; Takano T
    Can J Physiol Pharmacol; 2013 Oct; 91(10):773-82. PubMed ID: 24144047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Rho family of small GTPases is involved in epithelial cystogenesis and tubulogenesis.
    Rogers KK; Jou TS; Guo W; Lipschutz JH
    Kidney Int; 2003 May; 63(5):1632-44. PubMed ID: 12675838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes.
    Yanagida-Asanuma E; Asanuma K; Kim K; Donnelly M; Young Choi H; Hyung Chang J; Suetsugu S; Tomino Y; Takenawa T; Faul C; Mundel P
    Am J Pathol; 2007 Aug; 171(2):415-27. PubMed ID: 17569780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reno-protective effect of a phosphoinositide 3-kinase inhibitor wortmannin on streptozotocin-induced proteinuric renal disease rats.
    Kim SH; Jang YW; Hwang P; Kim HJ; Han GY; Kim CW
    Exp Mol Med; 2012 Jan; 44(1):45-51. PubMed ID: 22056625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RhoA, Rac1, and Cdc42 exert distinct effects on epithelial barrier via selective structural and biochemical modulation of junctional proteins and F-actin.
    Bruewer M; Hopkins AM; Hobert ME; Nusrat A; Madara JL
    Am J Physiol Cell Physiol; 2004 Aug; 287(2):C327-35. PubMed ID: 15044152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho-family small GTPases are involved in forskolin-induced cell-cell contact formation of renal glomerular podocytes in vitro.
    Gao SY; Li CY; Shimokawa T; Terashita T; Matsuda S; Yaoita E; Kobayashi N
    Cell Tissue Res; 2007 May; 328(2):391-400. PubMed ID: 17265067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chloride intracellular channel 5A stimulates podocyte Rac1, protecting against hypertension-induced glomerular injury.
    Tavasoli M; Li L; Al-Momany A; Zhu LF; Adam BA; Wang Z; Ballermann BJ
    Kidney Int; 2016 Apr; 89(4):833-47. PubMed ID: 26924049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FHL2 mediates podocyte Rac1 activation and foot process effacement in hypertensive nephropathy.
    Li SY; Chu PH; Huang PH; Hsieh TH; Susztak K; Tarng DC
    Sci Rep; 2019 Apr; 9(1):6693. PubMed ID: 31040292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissection of Glomerular Transcriptional Profile in Patients With Diabetic Nephropathy: SRGAP2a Protects Podocyte Structure and Function.
    Pan Y; Jiang S; Hou Q; Qiu D; Shi J; Wang L; Chen Z; Zhang M; Duan A; Qin W; Zen K; Liu Z
    Diabetes; 2018 Apr; 67(4):717-730. PubMed ID: 29242313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases.
    Dong N; Meng L; Xue R; Yu M; Zhao Z; Liu X
    Int Urol Nephrol; 2017 Aug; 49(8):1489-1506. PubMed ID: 28528353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARHGEF7 (
    Matsuda J; Maier M; Aoudjit L; Baldwin C; Takano T
    J Am Soc Nephrol; 2020 May; 31(5):996-1008. PubMed ID: 32188698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in slit diaphragm signaling.
    New LA; Martin CE; Jones N
    Curr Opin Nephrol Hypertens; 2014 Jul; 23(4):420-30. PubMed ID: 24867674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rho GTPases in kidney physiology and diseases.
    Steichen C; Hervé C; Hauet T; Bourmeyster N
    Small GTPases; 2022 Jan; 13(1):141-161. PubMed ID: 34138686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin controls cytoskeleton reorganization and filtration barrier permeability via the PKGIα-Rac1-RhoA crosstalk in cultured rat podocytes.
    Rachubik P; Szrejder M; Rogacka D; Typiak M; Audzeyenka I; Kasztan M; Pollock DM; Angielski S; Piwkowska A
    Biochim Biophys Acta Mol Cell Res; 2022 Sep; 1869(9):119301. PubMed ID: 35642843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rho GTPases in embryonic development.
    Duquette PM; Lamarche-Vane N
    Small GTPases; 2014; 5(2):8. PubMed ID: 25483305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.